A study to evaluate the clinical outcomes of single nucleotide polymorphisms on pharmacokinetic genes in japanese patients with metastatic renal cell carcinoma.
Phase of Trial: Phase IV
Latest Information Update: 19 Aug 2015
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Biomarker; Pharmacokinetics; Therapeutic Use
- 19 Aug 2015 New trial record